LGALS3 and systemic sclerosis: In line with its in vitro pro-inflammatory function, it has been shown that the levels of galectin-3 are elevated in the serum or nidi of patients with inflammatory diseases including RA [72], systemic lupus erythematosus (SLE) [90], Behçet’s disease [91], and systemic sclerosis [92].